Altered allostery of the left flipper domain underlies the weak ATP response of rat P2X5 receptors

  1. Ye Yu,**,‡‡4
  1. Institute of Medical Sciences and Department of Pharmacology and Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  2. §Putuo District Center Hospital, Shanghai University of Chinese Traditional Medicine, Shanghai 200026, China
  3. Department of Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center, Houston, Texas 77030
  4. State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmacy, Guangxi Normal University, Guilin 541004, China
  5. **College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China
  6. ‡‡Department of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China
  1. 2 To whom correspondence may be addressed. Tel.: 86-21-6445-3296; Fax: 86-21-6445-3296; E-mail: hshwang2002{at}163.com.
  2. 3 To whom correspondence may be addressed. Tel.: 86-21-6445-3296; Fax: 86-21-6445-3296; E-mail: crguocpu{at}126.com.
  3. 4 To whom correspondence may be addressed. Tel.: 86-21-6445-3296; Fax: 86-21-6445-3296; E-mail: yuye{at}shsmu.edu.cn.
  1. 1 These authors contributed equally to this work.

  2. Edited by Roger J. Colbran

Abstract

Although the extracellular ATP-gated cation channel purinergic receptor P2X5 is widely expressed in heart, skeletal muscle, and immune and nervous systems in mammals, little is known about its functions and channel-gating activities. This lack of knowledge is due to P2X5's weak ATP responses in several mammalian species, such as humans, rats, and mice. WT human P2X5 (hP2X5Δ328–349) does not respond to ATP, whereas a full-length variant, hP2X5 (hP2X5-FL), containing exon 10 encoding the second hP2X5 transmembrane domain (TM2), does. However, although rat P2X5 (rP2X5) has a full-length TM2, ATP induces only weak currents in rP2X5, which prompted us to investigate the mechanism underlying this small ATP response. Here, we show that single replacements of specific rP2X5 residues with the corresponding residues in hP2X5 (S191F or F195H) significantly enhance the current amplitude of rP2X5. Using a combination of engineered disulfide cross-linking, single-channel recording, and molecular modeling, we interrogated the effects of S191F and F195H substitutions on the allostery of the left flipper (LF) domain. On the basis of our findings, we propose that the bound ATP-induced distinct allostery of the LF domain with that of other functional subtypes has caused the weak ATP response of rP2X5 receptors. The findings of our study provide the prerequisite for future transgenic studies on the physiological and pathological functions of P2X5 receptors.

Footnotes

  • This study was supported by Guangxi Funds for Distinguished Experts, National Natural Science Foundation of China, Grants 31971146, 81603409, 31971042, 21977021, 31900808, 31570832, 31170787, 31400707, and 81703677; National Postdoctoral Program for Innovative Talents Grant BX201700306; China Postdoctoral Science Foundation Grant 2018M632127; the Project Program of the State Key Laboratory of Natural Medicines of China Pharmaceutical University; National Program on Key Basic Research Project of China Grant 2014CB910300/02; National Excellent Young Scientist Foundation of China Grant 31222018; Hunan Provincial Natural Science Foundation of China Grant 2018JJ1012; and Science and Technology Department of Hunan Province Grant 2018RS3086. The authors declare that they have no conflicts of interest with the contents of this article.

  • Received June 28, 2019.
  • Revision received November 12, 2019.

Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.

Table of Contents

This Article

  1. The Journal of Biological Chemistry 294, 19589-19603.
  1. All Versions of this Article:
    1. RA119.009959v1
    2. 294/51/19589 (most recent)

Article Usage Stats

Submit your work to JBC.

You'll be in good company.